Skip to content

T Cell Chronic Lymphocytic Lymphoma Leukemia C4025181

Published: July 22, 2026Updated: August 20, 2026

A type of blood cancer where abnormal T cells multiply out of control. Treatment may include chemotherapy, targeted drugs, or stem cell transplant depending on disease stage.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Painless lymphadenopathy

(hematologic)

Hepatosplenomegaly

(hematologic)

B symptoms (fever, weight loss)

(hematologic)

Hypercalcemia

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Chemotherapy Regimen

Systemic chemotherapy using agents such as fludarabine, cyclophosphamide, and rituximab to target malignant T-cell populations and induce remission.

medication
2

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Targeted Immunotherapy

Monoclonal antibody therapy targeting specific T-cell antigens to selectively eliminate malignant cells while preserving normal immune function.

medication

Additional treatment options

Leukapheresis

Procedure to remove excess malignant lymphocytes from circulation in cases of high tumor burden or hyperleukocytosis causing complications.

procedure

Allogeneic Stem Cell Transplant

Potentially curative treatment involving high-dose chemotherapy followed by infusion of stem cells from compatible donor to replace malignant cell compartment.

surgical

Minimal Residual Disease (MRD) Monitoring

Sensitive molecular testing to detect residual disease at levels undetectable by conventional methods, guiding treatment decisions and predicting relapse.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is T Cell Chronic Lymphocytic Lymphoma Leukemia C4025181?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hallek M, Shanafelt TD, Eichhorst B. Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2023.

guideline2023
2

Hoechstetter MA, Busch R, Eichhorst B. Prognostic factors and treatment options in chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2022.

review2022
3

Byrd JC, Furman RR, Coutre SE. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med. 2015.

clinical_trial2015
4

Dreger P, Ghia P, Schetelig J. Defining the optimal strategy for patients with chronic lymphocytic leukemia in the era of novel agents. J Clin Oncol. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat T Cell Chronic Lymphocytic Lymphoma Leukemia C4025181. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy